Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

ClinicalTrials.gov ID: NCT00778700

Public ClinicalTrials.gov record NCT00778700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Vehicle-Controlled Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study was double-blind, randomized, vehicle-controlled study with application of Ruxolitinib phosphate cream or vehicle cream in participants with stable plaque psoriasis applied once daily for 12 weeks without occlusive dressings. There were 4 treatment groups anticipated to have 50 participants in each.

Study identification

NCT ID
NCT00778700
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
199 participants

Conditions and interventions

Conditions

Interventions

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2008 (Actual)
Primary completion
Jun 26, 2009 (Actual)
Completion
Jun 26, 2009 (Actual)
Last update posted
Feb 9, 2022

2008 – 2009

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
Not listed Hot Springs Arkansas — —
Not listed Los Angeles California — —
Not listed San Diego California — —
Not listed Santa Monica California — —
Not listed Vallejo California — —
Not listed New Haven Connecticut — —
Not listed Miami Florida — —
Not listed Ormond Beach Florida — —
Not listed Naperville Illinois — —
Not listed Wheaton Illinois — —
Not listed Evansville Indiana — —
Not listed South Bend Indiana — —
Not listed Boston Massachusetts — —
Not listed Clinton Township Michigan — —
Not listed Fridley Minnesota — —
Not listed St Louis Missouri — —
Not listed Albuquerque New Mexico — —
Not listed Rochester New York — —
Not listed Norman Oklahoma — —
Not listed Simpsonville South Carolina — —
Not listed Austin Texas — —
Not listed College Station Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Salt Lake City Utah — —
Not listed Norfolk Virginia — —
Not listed Walla Walla Washington — —
Not listed Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00778700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2022 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00778700 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →